AJMC May 25, 2023
Although lack of routine testing and limitations to current diagnostic testing likely lead to underreporting of respiratory syncytial virus, RSV still poses a substantial economic burden.
Respiratory syncytial virus (RSV) was found to be an economic burden despite probable underreporting due to lack of routine testing, according to a study published in Journal of Medical Economics.
RSV is a seasonal virus that affects children and older adults. Approximately 470,000 adults 60 years and older have experienced an RSV-associated hospitalization and 33,000 in-hospital deaths areassociated with RSV. The management of acute respiratory infections has been previously estimated but did not report respiratory pathogen-specific management costs, the authors of the present study noted. This systematic literature review aimed to summarize...